Antimicrobial Susceptibility Testing Market is segmented by Product (Manual {Susceptibility Discs, Plates, MIC Strips}, Consumables, Automated), Method (Diffusion, Dilution), Application (Clinical Diagnostics), End User (Hospitals, Pharma, Institutes)

The Antimicrobial Susceptibility Testing (AST) is a laboratory procedure utilized to determine the proper antimicrobial regimen against microbes. Achieving an appropriate antimicrobial therapy is essential when it needs AST as a causative agent.

The Antimicrobial Susceptibility Testing Market is projected to grow at a CAGR of 6.4% from 2022 to 2031 reaching a market size value of USD 5.99 billion by 2031.

This market is primarily driven by growth factors such as, high number of infectious disease cases, increased initiatives from the government and financial support in antimicrobial susceptibility testing programs, advancements in technology regarding innovations in new AST methods, and growth of multi-drug resistance in microorganisms. Other growth drivers that can offer significant opportunities in this market are, rising number of emerging markets, and progressive researches in developing rapid antimicrobial susceptibility testing.

COVID-19 Impact Assessment

The rise of COVID-19 cases can be one of the negative factors that can hinder the growth of Antimicrobial Susceptibility Testing Market since hospitals and medical clinics have a surge when it comes to the volume of COVID-19 cases. Hospitals and laboratories prioritized COVID-19 cases and is limited when it comes to physical interaction because controlling the spread of virus is of top priority. The strict protocols and lock downs imposed by the governments globally, caused the decline of scheduled experiments and facility operations because most of it have already been postponed.

There is a disruption of the supply chain, and has affected distribution and manufacturing in facilities in prominent companies across the globe and ever since then, demand for antimicrobial susceptibility testing has decreased. This can be considered a big set back in the growth of the market because if manufacturing and distribution of products and equipment are affected, production and sales will also be negatively affected making it challenging for these companies to meet demands of end users. Suppliers of antimicrobial susceptibility testing equipment also had the challenge of exporting and importing raw materials for processing of their products since there have been borders restriction resulting to fewer sales and availability of products.

Key Findings in the Global Antimicrobial Susceptibility Testing Market

In terms of product, manual antimicrobial susceptibility testing products segment is projected to have a large share in the revenue in terms of product in 2022. this segment includes susceptibility discs, susceptibility plates, and minimum inhibitory concentration strips. The factors driving the demand for conventional AST techniques are, increasing number of the use of AST in terms of antimicrobial therapy as well as the growing antibiotic resistance cases. Factors driving manual antimicrobial susceptibility testing and related products market are, disc diffusion technique high penetration and innovations in susceptibility plates.

In terms of application, clinical diagnostics segment is anticipated to have a large share in the revenue of the market in 2022. This is due to antibiotic resistance, HAIs increasing frequency, rising number of procedural volume in clinical diagnostic tests, awareness on effective and advance disease diagnosis in major markets, and the emergence of popularity of antimicrobial susceptibility testing methods among physicians.

In terms of end user, diagnostic laboratories and hospital segment is projected to generate the largest revenue accounted for in 2022. The large share is due to availability of facilities providing complete equipment and having experienced technicians, emergence of hospital-acquired infections, and growing initiatives from market key players in offering AST products to end users.

Regional Market Analysis

Asia Pacific is expected to have the fastest growing market during the forecast period. This is mainly attributed to the initiatives and efforts of the government, health authorities and medical professionals to fight off antimicrobial resistance, increasing consumption of antibiotics, and increasing concerns on Methicillin-resistant Staphylococcus aureus as well as emergence of sepsis and HIV/AIDS cases. China on the other hand is projected to have the largest market share in the region.

Key Players: Share and Competition

Based on an extensive assessment, these major key players in the Antimicrobial Susceptibility Testing market have a competitive landscape and utilizing key strategic developments to lead the industry over the past years until now. These companies are, Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).

Report Highlights
• Historical data available (as per request)
• Estimation/projections/forecast for revenue and unit sales (2022 – 2031)
• Data breakdown for every market segment (2022 – 2031)
• Gross margin and profitability analysis of companies
• Price analysis of each product type
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategy

Industry Segmentation and Revenue Breakdown

Product Analysis (Revenue, USD Million, 2022 - 2031)

• Manual Antimicrobial Susceptibility Testing Products
• Susceptibility Discs
• Susceptibility Plates
• Minimum Inhibitory Concentration (MIC) Strips
• Consumables
• Automated Antimicrobial Susceptibility Testing Products

Method Analysis (Revenue, USD Million, 2022 - 2031)

• Disc Diffusion
• Automated AST
• Dilution
• Other Methods
(Other methods include Etest, genotypic methods, and MALDI-TOF MS.)

Application Analysis (Revenue, USD Million, 2022 - 2031)

• Clinical Diagnostics
• Drug Discovery and Development
• Other Applications
(Other applications include epidemiology, veterinary diagnostic, and environmental monitoring)

End User Analysis (Revenue, USD Million, 2022 - 2031)

• Diagnostic Laboratories and Hospitals
• Pharmaceutical and Biotechnology Companies
• Research and Academic Institutes

Region Analysis (Revenue, USD Million, 2022 – 2031)

• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• UAE
• Qatar
• Saudi Arabia
• Japan
• Africa
• Rest of World

Available Versions:
• United States Antimicrobial Susceptibility Testing Industry Research Report
• Europe Antimicrobial Susceptibility Testing Industry Research Report
• Asia Pacific Antimicrobial Susceptibility Testing Industry Research Report

Need Report on a particular Country OR need a Tailored/Customized Research? Budget Limits/Price Discounts Query...!

Email to David Correa

david@marketdecipher.com 

OR Fill the below "Sample Request FORM" with your queries in the message box.